SEELOS THERAPEUTICS, INC. Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Seelos Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • Seelos Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $23K, a 229% increase year-over-year.
  • Seelos Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $91K, a 550% increase year-over-year.
  • Seelos Therapeutics, Inc. annual Interest Expense for 2023 was $75K, a 436% increase from 2022.
  • Seelos Therapeutics, Inc. annual Interest Expense for 2022 was $14K, a 99.1% decline from 2021.
  • Seelos Therapeutics, Inc. annual Interest Expense for 2021 was $1.6M, a 874% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $75K +$61K +436% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $14K -$1.58M -99.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $1.6M +$1.43M +874% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $164K +$135K +466% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-04
2019 $29K -$102K -77.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $131K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-17
2011 $377K -$8.47M -95.7% Jan 1, 2011 Dec 31, 2011 10-K 2012-03-13
2010 $8.85M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.